...
机译:级联基因筛查诊断出儿茶酚胺能性多形性室性心动过速突变阳性家庭成员的运动性心律失常高发
Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway|University of Oslo, Oslo, Norway|Institute for Surgical Research, Oslo University Hospital Rikshospitalet, Oslo, Norway;
University of Oslo, Oslo, Norway;
Medical Genetics Laboratory, Oslo University Hospital Rikshospitalet, Oslo, Norway;
Department of Cardiology, St. Olavs Hospital, Trondheim, Norway;
Department of Cardiology, St. Olavs Hospital, Trondheim, Norway|Norwegian University of Science and Technology, Trondheim, Norway;
Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway;
Department of Pediatrics, Oslo University Hospital Rikshospitalet, Oslo, Norway;
Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway|University of Oslo, Oslo, Norway|Institute for Surgical Research, Oslo University Hospital Rikshospitalet, Oslo, Norway;
Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo 0027, Norway;
Medical Genetics Laboratory, Oslo University Hospital Rikshospitalet, Oslo, Norway;
机译:级联基因筛查诊断为儿茶酚胺能性多态性室性心动过速突变阳性家庭成员,运动诱发的心律失常高发。
机译:氟卡尼对基因型阴性儿茶酚胺能多形性室性心动过速患者运动性心律失常和复发的影响
机译:Flecainide疗法可抑制CASQ2相关儿茶酚胺能性多形性室性心动过速患者运动引起的室性心律失常
机译:基于“固定”雷马丁受体泄漏的心力衰竭和运动诱导的心室性心动过速的新疗法
机译:通过线性和非线性方法分析单形性室性心动过速,多形性室性心动过速和室颤的特征。
机译:Flecainide对运动诱导的运动诱导的心律失常心律失常和复发性的基因型阴性患者的影响
机译:氟卡尼对患有儿茶酚胺能性多形性室性心动过速的基因型阴性患者运动性心律失常和复发的影响。